Loading
Latest filing published 26 Feb 2016 for Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.), €3,349.
No signal scores available.
Only one filing by Lyne Fortin is known so far (26 February 2016): an open-market purchase, €3,349, in Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.). That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration